News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-02-29 4:3:35 pm Revance Therapeutics Inc. (RVNC) Q4 2023 Earnings Call Transcript SeekingAlpha
2024-02-29 3:41:48 am Q4 2023 Revance Therapeutics Inc Earnings Call Thomson Reuters StreetEvents
2024-02-28 1:43:30 pm Revance Therapeutics Inc (RVNC) Reports Strong Revenue Growth in Q4 and Full Year 2023 GuruFocus.com
2024-02-28 1:5:0 pm Revance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Update Business Wire
2024-02-21 5:1:0 am Revance to Release Fourth Quarter and Full Year 2023 Financial Results on Wednesday February 28, 2024 Business Wire
2024-02-21 5:0:0 am Revance to Participate in Upcoming Investor Conferences Business Wire
2024-02-20 2:10:4 pm Halozyme Therapeutics (HALO) Q4 Earnings Match Estimates Zacks
2024-02-02 5:0:0 am Revance Receives Permanent J-Code for DAXXIFY® and Announces Publication of DAXXIFY Pivotal Study (ASPEN-1) Results in Neurology® Business Wire
2024-02-01 5:0:0 am Revance to Participate in the Guggenheim 6th Annual Biotechnology Conference Business Wire
   

Please consider a small donation if you think this website provides you with relevant information